Concepedia

Stefanie Elm

SE

2

Publications

301

Citations

2

H-Index

2005

Active since

Affiliations

Amgen (Germany)(Current)

Stefanie Elm is an author at Amgen (Germany) specializing in tumor immunology, cancer research, and cancer therapeutics.

Top concepts

Publications per year

2005–2018

2

Publications

2

A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors

Maxim Kebenko, Marie-Elisabeth Goebeler, M. Wolf et al. · OncoImmunology · 2018 · 170 citations · Full text

, , +19

High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G

Susanne Preithner, Stefanie Elm, Sandra Lippold et al. · Molecular Immunology · 2005 · 131 citations · Full text

Rows per page

1–2 of 2